Valuation: Parnax Lab Limited

Market Cap 1.26B 13.44M 12.05M 11.02M 10.06M 18.95M 19.54M 133M 52.95M 674M 50.45M 49.37M 2.13B P/E 2025
10.7x
P/E 2026 12.5x
Enterprise Value 2.07B 22.01M 19.74M 18.04M 16.47M 31.02M 32M 217M 86.7M 1.1B 82.6M 80.83M 3.48B EV / Sales 2025
1.02x
EV / Sales 2026 0.92x
Free-Float
14.66%
Yield 2025 *
-
Yield 2026 -
1 day+0.91%
1 week+4.67%
Current month+4.67%
1 month-5.13%
3 months-16.70%
6 months-31.63%
Current year-14.62%
1 week 92.35
Extreme 92.35
111
1 month 92.35
Extreme 92.35
121
Current year 92.35
Extreme 92.35
182
1 year 92.35
Extreme 92.35
182
3 years 75.6
Extreme 75.6
193.5
5 years 24
Extreme 24
193.5
10 years 11.65
Extreme 11.65
193.5
Manager TitleAgeSince
Chief Executive Officer - 2024-07-04
Director of Finance/CFO 42 2024-07-04
Compliance Officer - 2021-06-20
Director TitleAgeSince
Director/Board Member 50 2015-03-30
Director/Board Member 72 2021-05-27
Director/Board Member 67 2023-08-10
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%+4.67%-11.69%+26.14% 12.47M
-0.79%-4.48%+46.48%+118.69% 1,206B
+1.43%+1.11%+48.05%+83.72% 665B
+1.07%-1.21%+32.92%+105.10% 515B
-0.36%-3.25%+45.42%+63.89% 381B
-0.14%-1.87%+70.06%+40.55% 362B
-0.78%-0.52%+30.47%+56.79% 307B
-0.80%-0.21%+7.98%+36.97% 289B
+0.03%-1.20%+43.79%+68.49% 249B
-0.41%-2.22%+40.43%+114.24% 207B
Average +0.02%-1.76%+35.39%+71.46% 417.98B
Weighted average by Cap. -0.04%-1.96%+42.71%+86.30%

Financials

2025 2026
Net sales 1.88B 19.98M 17.92M 16.37M 14.95M 28.16M 29.05M 197M 78.7M 1B 74.98M 73.37M 3.16B 2.49B 26.45M 23.72M 21.68M 19.79M 37.28M 38.46M 261M 104M 1.33B 99.26M 97.13M 4.19B
Net income 115M 1.23M 1.1M 1M 917K 1.73M 1.78M 12.11M 4.83M 61.46M 4.6M 4.5M 194M 118M 1.25M 1.12M 1.03M 937K 1.77M 1.82M 12.38M 4.94M 62.84M 4.7M 4.6M 198M
Net Debt 690M 7.34M 6.58M 6.01M 5.49M 10.34M 10.67M 72.5M 28.91M 368M 27.54M 26.95M 1.16B 805M 8.57M 7.68M 7.02M 6.41M 12.08M 12.46M 84.63M 33.75M 430M 32.15M 31.46M 1.36B
Projected Income Statement - Annual - Parnax Lab Limited
Logo Parnax Lab Limited
Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.
Employees
12
Date Price Change Volume
26-11-08 ₹111.00 +0.91% 9
26-11-08 ₹110.00 +7.79% 2
26-11-06 ₹102.05 -0.92% 114
26-11-05 ₹103.00 +1.93% 91
26-11-04 ₹101.05 -2.84% 2,661
  1. Stock Market
  2. Stocks
  3. PARNAXLAB Stock